Corcept Therapeutics Incorporated · NASDAQ:CORT

Robb Gary Charles received 328 Corcept Therapeutics Incorporated shares as an award (Form 4)

Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026

From Sep 1 to Sep 2, 2026, Robb Gary Charles (Chief Business Officer) received 328 Corcept Therapeutics Incorporated shares as an award at US$113.38 for US$18,594, leaving 13,663 shares. Filed Sep 3, 2026 (Form 4).

Awarded
328 shares
Price
US$113.38
Value
US$18,594
Holding after
13,663 shares
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockAward164US$113.3813,590Direct
Sep 1, 2026Common StockAward16413,754Direct
Sep 2, 2026Common StockShares withheld for tax91US$113.3813,663Direct

Source

View original at SEC

Related